• We are exhibiting at Linus Dagarna together with EMM Life Science AB (LinkedIN)
    VΓ€xjΓΆ, September 19-21, 2023

  • We closed our first investment round and raised 7M SEK! πŸš€πŸš€πŸš€

    The investors include ALMI Invest, together with life science angel investors and the Propel Capital. More information can be found in our press releases. (EnglishSwedish)
    May 24, 2023

  • We presented results of our clinical performance study at Karolinska University Hospital at ECCMID 2023 (here)

  • 22 new companies of Sting are announced in Dagens Industri and UTI-lizer is one of them!
    September 7, 2022

  • We got support from Vinnova! πŸŽ‰πŸŽ‰πŸŽ‰
    Our preparatory project for international proposal is accepted. We will be setting a multi-center clinical trial for our tests at the point-of-care.
    June 13, 2022

  • We successfully completed first extensive clinical validation and performance study of our tests at the Karolinska University Hospital! πŸš€πŸ’― (post)
    June 1, 2022

  • UTI-lizer has joined the leading Nordic incubator Sting! πŸ™Œ 
    May 1, 2022

  • UTI-lizer has been selected as one of the Hello Tomorrow Deep Tech Pioneers!
    September 23, 2021

  • UTI-lizer got the EIT Health Wildcard! We have participated in EIT Health Wildcard Hackathon.
    July 1-10, 2020